end of life - Nursing Case Study
Pathophysiology
• Primary mechanism: Organ Failure - As the body approaches end of life, critical organs such as the heart, kidneys, and liver progressively lose function, leading to systemic imbalances. The heart's reduced ability to pump blood efficiently causes decreased perfusion and subsequent multi-organ dysfunction.
• Secondary mechanism: Metabolic Imbalance - Metabolic disturbances, including electrolyte imbalances and acid-base shifts, occur due to impaired organ function. These changes lead to further decline, contributing to muscle weakness, arrhythmias, and altered mental status.
• Key complication: Respiratory Decline - Diminished respiratory function results from muscle weakness, fluid overload, and neurological decline, causing hypoxia and carbon dioxide retention, which exacerbate organ dysfunction and hasten the dying process.
Patient Profile
Demographics:
72-year-old female, retired school teacher
History:
• Key past medical history: Chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), type 2 diabetes mellitus
• Current medications: Lisinopril, Metformin, Albuterol inhaler, Furosemide, Insulin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing shortness of breath and fatigue
• Key symptoms: Persistent cough, edema in lower extremities, decreased appetite, confusion
• Vital signs: Blood pressure 98/65 mmHg, heart rate 112 bpm, respiratory rate 28 breaths per minute, temperature 99.1°F, oxygen saturation 88% on room air
Section 1
As the healthcare team evaluates the patient's condition, new diagnostic results reveal significant insights into her deteriorating status. Blood gas analysis indicates a pH of 7.32, PaCO2 of 55 mmHg, and HCO3- of 28 mEq/L, confirming a state of respiratory acidosis with metabolic compensation. This aligns with the clinical picture of COPD exacerbation and reduced respiratory efficiency, contributing to her worsening hypoxia and carbon dioxide retention. Additionally, a comprehensive metabolic panel shows elevated creatinine levels at 2.1 mg/dL, signaling declining renal function likely exacerbated by her heart failure and diabetes. Electrolyte imbalances are evident, with potassium at 3.0 mEq/L, highlighting the risk for cardiac arrhythmias given her current heart rate and blood pressure status.
The patient's chest X-ray further corroborates the clinical suspicion of fluid overload, revealing bilateral pulmonary congestion with interstitial edema. This finding, along with her diminished respiratory function, suggests that the heart's ability to manage fluid volume is severely compromised, leading to increased pulmonary pressures and subsequent respiratory decline. Despite ongoing treatment with Furosemide, the patient's edema persists, and her oxygen saturation remains critically low at 88% on room air, even after supplemental oxygen is provided.
These developments necessitate a reassessment of her current management plan, focusing on optimizing her respiratory support and addressing her electrolyte imbalances. The healthcare team considers the use of non-invasive ventilation to assist with ventilation, aiming to improve gas exchange and alleviate the work of breathing. Additionally, adjustments to her diuretic regimen and cautious electrolyte repletion are planned to stabilize her cardiovascular status. These interventions are critical as the patient navigates the delicate balance of managing her chronic conditions amidst the progression of end-of-life organ failure.
Section 2
Response to Interventions
Following the implementation of the revised management plan, the healthcare team closely monitors the patient's response to the interventions. The initiation of non-invasive ventilation (NIV) shows a promising initial improvement in her respiratory status. Her oxygen saturation increases to 92% with the support of NIV, indicating a positive effect on her gas exchange and reduced work of breathing. However, after several hours, the patient begins to exhibit signs of increased respiratory distress, including tachypnea with a respiratory rate climbing to 32 breaths per minute and persistent use of accessory muscles. This suggests that while NIV provided temporary relief, her underlying respiratory failure continues to progress.
Simultaneously, the team addresses her electrolyte imbalances with cautious potassium repletion. Reassessment reveals an increase in serum potassium to 3.5 mEq/L, within the lower end of the normal range, reducing the immediate risk of arrhythmias. However, her renal function continues to decline, evidenced by a rising creatinine level now at 2.4 mg/dL, indicating worsening renal insufficiency. This progression complicates fluid management, as the balance between diuresis and renal protection becomes increasingly precarious.
Despite these efforts, the patient's hemodynamic status becomes more unstable. Her blood pressure drops to 94/58 mmHg, and she develops an irregular heart rhythm consistent with atrial fibrillation with rapid ventricular response, likely precipitated by her electrolyte shifts and fluid overload. This new complication requires immediate attention and further reassessment of her treatment plan, as the team considers the potential benefits and risks of introducing anti-arrhythmic therapy and adjusting her diuretic regimen. The unfolding scenario underscores the complexity of managing interconnected organ systems in the context of end-of-life care, necessitating ongoing critical thinking and adaptability by the healthcare team.
Section 3
New Diagnostic Results
As the patient's condition continues to evolve, the healthcare team orders a series of diagnostic tests to gain further insights into her deteriorating status. An arterial blood gas analysis reveals a concerning development: the patient's pH has dropped to 7.28, indicating a state of metabolic acidosis. The partial pressure of carbon dioxide (PaCO2) is elevated at 52 mmHg, suggesting that her respiratory system is struggling to compensate. This aligns with her increased respiratory distress and suggests that her respiratory failure is transitioning from a primarily hypoxemic to a mixed respiratory and metabolic derangement.
Additionally, the latest chest X-ray shows worsening bilateral infiltrates, consistent with progressive pulmonary edema. This finding, combined with her declining renal function and electrolyte imbalances, points to a complex interplay between her heart failure, kidney dysfunction, and respiratory compromise. These results prompt the healthcare team to contemplate the initiation of more aggressive interventions, such as invasive mechanical ventilation or renal replacement therapy, while weighing the patient's overall prognosis and goals of care.
The patient's complete blood count indicates a rising white blood cell count of 16,000/mm³, raising suspicion for a possible infectious process that could be exacerbating her current state. Blood cultures are drawn to investigate potential sepsis as a complicating factor. The healthcare team must now integrate these new diagnostic insights with the patient's clinical presentation, considering the potential need for broad-spectrum antibiotics while remaining vigilant for the risk of further hemodynamic instability. This multifaceted scenario requires an agile approach to care, balancing aggressive treatment with the patient's end-of-life wishes, and preparing for critical care interventions if her condition continues to decline.
Section 4
Change in Patient Status
As the healthcare team monitors the patient's condition, they observe a notable change in her status. Her respiratory effort increases significantly, with a respiratory rate now climbing to 32 breaths per minute. Despite supplemental oxygen, her oxygen saturation drops to 84%, indicating a worsening of her respiratory failure. Her blood pressure has decreased to 88/54 mmHg, and her heart rate is tachycardic at 112 beats per minute, suggesting a possible progression toward septic shock. The patient is visibly anxious and increasingly lethargic, with a declining Glasgow Coma Scale score, now at 11, indicating deteriorating neurological status likely due to hypoxemia and acidosis.
In response to these changes, the healthcare team urgently reassesses her hemodynamic stability and considers the need for immediate interventions. An arterial line is placed for continuous blood pressure monitoring and frequent blood gas analysis. The team deliberates the initiation of invasive mechanical ventilation to alleviate her respiratory distress and improve gas exchange. Concurrently, they administer a fluid bolus cautiously, given her history of heart failure, to address her hypotension while preparing vasopressor support to sustain her blood pressure if she does not respond to fluids.
With the patient's clinical picture suggesting possible sepsis, empiric broad-spectrum antibiotics are initiated promptly after obtaining blood cultures. The team remains vigilant for signs of multi-organ dysfunction syndrome, given her renal impairment and potential septic state. As they manage these acute changes, the healthcare team maintains open communication with the patient’s family to align the treatment plan with her end-of-life care preferences, ensuring that any aggressive measures taken are consistent with her previously expressed wishes. This delicate balance between intervention and comfort care continues to guide the clinical decision-making process during this critical juncture.
Section 5
New Complications
Despite the timely interventions and diligent monitoring, the patient develops acute kidney injury, evidenced by a sudden increase in serum creatinine to 2.5 mg/dL from a baseline of 1.0 mg/dL. Additionally, her urine output has markedly decreased to less than 20 mL/hr, indicating oliguria, which is concerning for worsening renal function in the context of her suspected septic state. The healthcare team recognizes that the combination of hypotension and potential nephrotoxic effects from medications may have contributed to this complication. They decide to adjust her medication regimen, holding nephrotoxic drugs and reviewing the necessity and dosages of others in light of her renal impairment.
Simultaneously, the patient's blood gas analysis reveals a mixed metabolic and respiratory acidosis, with a pH of 7.25, PaCO2 of 55 mmHg, and HCO3- of 18 mEq/L. This finding correlates with her worsening respiratory failure and declining renal function, necessitating a reevaluation of her ventilatory support. The team considers increasing ventilatory settings or opting for alternative modes of ventilation to improve her acid-base balance and optimize oxygenation. They also explore the possibility of initiating renal replacement therapy if her renal function continues to deteriorate, aiming to prevent further complications from fluid overload and electrolyte imbalances.
Throughout these developments, the healthcare team remains focused on the patient's comfort and quality of life. They engage in ongoing discussions with the patient's family, ensuring transparency and alignment with her end-of-life care preferences. The team continues to weigh the benefits and burdens of aggressive interventions, emphasizing a patient-centered approach that honors her values and wishes. As they navigate these complex challenges, their clinical reasoning and decision-making are guided by a commitment to compassionate and ethical care during this critical phase of her illness.